Literature DB >> 862238

Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. IV. failure to inhibit mononuclear cell accumulation with niridazole.

U H Rudofsky, B Pollara.   

Abstract

Niridazole is a potent inhibitor of certain expressions of delayed-type hypersensitivity; however, its effect and specificity on other immunologically induced mononuclear cell infiltrates has not been determined. We therefore tested this drug in a model of auto-antibody-induced renal tubulointerstitial disease (RTD), which is characterized by the accumulation of lymphocytes and macrophages in the cortical interstitium. Niridazole-treated (100 mg/kg) and untreated guineapigs were injected with potent anti-tubular basement membrane serum from donors with RTD. Drug treatment was repeated 2-3 times during the course of 10 days. The characteristic renal lesions were found in both groups. However, a single dose of niridazole inhibited skin reactivity in tuberculin sensitive guinea-pigs for at least 8 days. These findings further support the contention that immunologic tissue injury in RTD does not involve mechanisms of delayed-type hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862238      PMCID: PMC1540953     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs. 1. Inhibition of tissue injury in leukocyte-depleted passive transfer recipients.

Authors:  U H Rudofsky; B Pollara
Journal:  Clin Immunol Immunopathol       Date:  1975-09

2.  Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity.

Authors:  A A Mahmoud; A Mandel; K Warren; L T Webster
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  The effect of carrageenan on delayed hypersensitivity reactions.

Authors:  H J Schwartz; S Leskowitz
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

4.  Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma.

Authors:  A A Mahmoud; K S Warren
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

5.  Renal tubular disease and autoantibodies against tubular basement membrane induced in guinea pigs.

Authors:  R W Steblay; U Rudofsky
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

6.  Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole.

Authors:  J C Daniels; I Fajardo; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

7.  Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs.1 II. passive transfer of renal lesions by anti-tubular basement membrane autoantibody and nonimmune bone marrow cells to leukocyte-depleted recipients.

Authors:  U H Rudofsky; B Pollara
Journal:  Clin Immunol Immunopathol       Date:  1976-07

8.  Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.

Authors:  J C Daniels; K S Warren; J R David
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  Transfer of experimental autoimmune renal cortical tubular and interstitial disease in guinea pigs by serum.

Authors:  R W Steblay; U Rudofsky
Journal:  Science       Date:  1973-06-01       Impact factor: 47.728

10.  Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.

Authors:  R P Pelley; R J Pelley; A B Stavitsky; A A Mahmoud; K S Warren
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

View more
  1 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.